[HTML][HTML] Exploring clinical and epidemiological characteristics of interstitial lung diseases: Rationale, aims, and design of a nationwide prospective registry—The …

…, M Pfeifer, J Behr, S Witt, D Kauschka… - BioMed research …, 2015 - hindawi.com
Despite a number of prospective registries conducted in past years, the current epidemiology
of interstitial lung diseases (ILD) is still not well defined, particularly regarding the …

Interims analysis of the EXCITING-ILD registry (registry for exploring clinical and epidemiological characteristics of interstitial lung diseases)

…, A Hellmann, M Pfeifer, J Behr, S Witt, D Kauschka… - 2016 - Eur Respiratory Soc
Background: The epidemiologic knowledge on interstitial lung diseases (ILD) is limited. The
multi-centre ILD registry “EXCITING” collects data on characteristics, management and …

Interim analysis of the EXCITING-ILD registry

…, A Hellmann, M Pfeifer, J Behr, S Witt, D Kauschka… - 2015 - Eur Respiratory Soc
Background: The epidemiologic knowledge on interstitial lung diseases (ILD) is limited. The
multi-centre, non-interventional prospective ILD registry “EXCITING” collects data on …

P097 Interim Analysis of the EXCITING-ILD registry (Registry for Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases)

…, R Leidl, M Pfeifer, J Behr, D Kauschka… - … Journal of Medicine, 2016 - academic.oup.com
Background: The epidemiologic knowledge on interstitial lung diseases (ILD) is limited. The
multi-centre registry “EXCITING” collects data on characteristics, management and …

Treatment and survival diversities in different forms of ILD in Germany-EXCITING registry

…, A Hellmann, M Pfeifer, J Behr, D Kauschka… - 2019 - Eur Respiratory Soc
Background: Real life data on outcome and treatment diversities in different ILD are scant.
Method: We analysed prospective data from the German EXCITING registry of consecutive …

Outcome differences between idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILD)-data from the EXCITING registry

…, M Pfeifer, J Behr, A Guenther, D Kauschka… - 2018 - Eur Respiratory Soc
Background: Available epidemiological data suggest that IPF is a frequent and unfavourable
fibrosing ILD. Yet, data on outcome differences between IPF and other ILDs are scant. …

European IPF Patient Charter: unmet needs and a call to action for healthcare policymakers

F Bonella, M Wijsenbeek… - European …, 2016 - Eur Respiratory Soc
Patient advocacy groups play an important role in supporting patients with chronic diseases
and promoting better care. The aim of this patient–physician initiative was to gather …

Costs of Pharmacological and Non-Pharmacological Interventions in Interstitial Lung Disease Management in Germany

PN Maqhuzu, L Schwarzkopf, P Markart, J Behr… - Respiration, 2022 - karger.com
Introduction: Interstitial lung diseases (ILDs) are associated with a high economic burden,
yet prospective data of the German healthcare system are sparse. Objective: We assessed …

[BOOK][B] The atheist and the holy city: encounters and reflections

G Klein - 1992 - books.google.com
Hauschka at the Institute for Cancer Research in Philadelphia, where I myself spent a few
months during my doctoral studies. HauschkaHauschka became very enthusiastic when he …

[HTML][HTML] CD133 positive embryonal rhabdomyosarcoma stem-like cell population is enriched in rhabdospheres

D Walter, S Satheesha, P Albrecht, BC Bornhauser… - PloS one, 2011 - journals.plos.org
Cancer stem cells (CSCs) have been identified in a number of solid tumors, but not yet in
rhabdomyosarcoma (RMS), the most frequently occurring soft tissue tumor in childhood. Hence…